日期: 2025-10-20
代码: 6978.HK
事件: 股东增减持（股东增减持）
天津众智科技发展于2025-10-20减持1934万股，最新持股数目9668万股，最新持股比例18.79% @#$ Tasly (Hong Kong) Pharmaceutical Investment Limited disposed of the -paid rights shares in Immunotech Biopharm Ltd (the "Company") on 20 October 2025 respectively, pursuant to the rights issue on the basis of one right share for every five existing shares held on the record date. Total shares held immediately before the relevant event in box 18 included the entitlement of 19,335,714 -paid rights shares.